Oppenheimer Feels Positive About VistaGen's 'Best-In-Class' Antidepressant, Sets $6 Target
May 24, 2018 at 17:05 PM EDT
Shares of VistaGen Therapeutics Inc (NASDAQ: VTGN) rocketed up over 40 percent to $1.36 in after-hours trading on Thursday — a ...